Subsequently, analysis of ARSB immunochemistry in prostate cancer tissue microarrays including nearly 300 cases showed that lower ARSB intensity scores were associated with higher Gleason scores and with increase in biochemical recurrences [42,43]. This evidence concerns the gene ARSB and prostate cancer.